| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/05/2006 | CA2589565A1 Amido compounds and their use as pharmaceuticals |
| 01/05/2006 | CA2572135A1 Sulfonamide compound |
| 01/05/2006 | CA2571356A1 Novel hexafluoroisopropanol derivatives |
| 01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/04/2006 | EP1612207A1 Processes and intermediates for preparing 2-substituted piperidine stereoisomers |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611902A1 Preventive and/or therapeutic agent for neuropathic pain |
| 01/04/2006 | EP1611168A1 Hexadentate ligand and catalytic complex therewith |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611102A2 Using alkylmetal reagents for directed metalation of azaaromatics |
| 01/04/2006 | EP1611101A1 Substituted pyridines via boronic acid coupling |
| 01/04/2006 | EP1611100A1 Novel n-substituted 2-aminopyridine derivatives |
| 01/04/2006 | EP1611099A1 Novel 6-substituted 2-aminopyridine derivatives |
| 01/04/2006 | EP1611096A2 Benzamide modulators of metabotropic glutamate receptors |
| 01/04/2006 | EP1611092A1 Pleuromutilin derivatives, process for their preparation and uses thereof |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
| 01/04/2006 | EP1611089A2 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer's disease |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610792A1 Calcium channel blockers comprising two benzhydril moieties |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1531673B1 Novel 2-pyridylethylbenzamide derivative |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP0885885B1 Pyridone derivatives and herbicides |
| 01/04/2006 | CN1717411A Phosphorescence compound and electro field light emitting device having the same |
| 01/04/2006 | CN1717391A Inhibitors of glycogen synthase kinase 3 |
| 01/04/2006 | CN1717388A Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation |
| 01/04/2006 | CN1234775C Azodyes, preparing method thereof and use |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234690C Nicotinic acid ester of resveratrol and its synthetic method |
| 01/04/2006 | CN1234689C Production method for ether compound |
| 01/03/2006 | US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents |
| 01/03/2006 | US6982335 Synthesis of substituted thiazoline carboxylic acids |
| 01/03/2006 | US6982285 Control of parasites attached to skin of fish |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | CA2244695C Cyclic amic acid derivatives |
| 12/29/2005 | WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides |
| 12/29/2005 | WO2005123726A1 Pyridinyl-isoxazoles and their use as herbicides |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123683A1 Method for purifying nicotinic acid |
| 12/29/2005 | WO2005123682A1 Method for the production of 5-aryl nicotinaldehydes |
| 12/29/2005 | WO2005123681A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 12/29/2005 | WO2005123680A1 Six-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005123676A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 12/29/2005 | WO2005123668A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/29/2005 | WO2005079398A3 Drug conjugates |
| 12/29/2005 | WO2005009104A3 Benzoic and phenyl acetic acid derivatives as hnf-4 modulators |
| 12/29/2005 | US20050288512 Advanced contaminate treatment system |
| 12/29/2005 | US20050288511 Process for the preparation of 4-trifluoromethyl-2(1H)-pyridinone |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 12/29/2005 | US20050288338 Amido compounds and their use as pharmaceuticals |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288336 Cysteine protease inhibitors |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288258 Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| 12/29/2005 | US20050288238 Benzocyclodecane derivatives with antitumor activity |
| 12/29/2005 | US20050288187 Inhibitor development for 4-hydroxyphenylpyruvate dioxygenase, employing tyrosinemia 1 as a model for human diseases mediated by 2-oxoacid utilizing dioxygenases |
| 12/29/2005 | DE102004029309A1 Pyridinylisoxazole und ihre Verwendung als Herbizide Pyridinylisoxazole and their use as herbicides |
| 12/29/2005 | DE102004027414A1 Gasphasenoxidation von alkylsubstituierten heterozyklischen Verbindungen Gas-phase oxidation of alkyl-substituted heterocyclic compounds |
| 12/29/2005 | CA2570529A1 Pyridinyl-isoxazoles and their use as herbicides |
| 12/29/2005 | CA2570258A1 Bi- or tetra-guanidino-biphenyl compounds as small molecule carriers |
| 12/29/2005 | CA2569459A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 12/28/2005 | EP1610126A1 A system for determining the electrical potential across a membrane |
| 12/28/2005 | EP1609791A1 Preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-Chloro-2-thienyl)methy]propy]amino]-3H-imidazo[4,5-b]pyridin-3-y]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide |
| 12/28/2005 | EP1609362A2 Non-systemic control of parasites |
| 12/28/2005 | EP1608639A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 12/28/2005 | EP1608624A2 6-alkyl or alkenyl-4-aminopicolinates and their use as herbicides |
| 12/28/2005 | EP1608623A1 Metal ion chelators and therapeutic use thereof |
| 12/28/2005 | EP1608622A2 Biaryl substituted 6-membered heterocyles as sodium channel blockers |
| 12/28/2005 | EP1608621A1 Process for preparing 2,6-divinylpyridine and 2-methyl-6-vinylpyridine from 2,6-lutidine over modified zeolites |
| 12/28/2005 | EP1608617A1 Muscarinic agonists |
| 12/28/2005 | EP1608371A1 Process for the preparation of donepezil and derivatives thereof |
| 12/28/2005 | EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases |
| 12/28/2005 | EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 12/28/2005 | EP1031563B1 Sulfonyl derivatives |
| 12/28/2005 | EP1000932B9 Aromatic ring derivatives |
| 12/28/2005 | EP0977484B1 Non-spherical and non-platelet pyrithione salts |
| 12/28/2005 | EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma |
| 12/28/2005 | CN1714081A Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 12/28/2005 | CN1714080A Substituted pyridyloxyalkylamides and their use as fungicides |
| 12/28/2005 | CN1714079A Mandelic acid derivatives |
| 12/28/2005 | CN1714076A Novel aryl ureido benzoic acid derivatives and their use |
| 12/28/2005 | CN1714060A Method for deuteration or tritiation of heterocyclic ring |
| 12/28/2005 | CN1713818A Pyridylpropynyloxyphenyl derivatives for use as herbicides |
| 12/28/2005 | CN1233618C Benzoylcyclohexanone amine compounds with herbicidal activity |
| 12/27/2005 | US6979739 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 12/27/2005 | US6979695 Compounds capable of activating cholinergic receptors |
| 12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
| 12/27/2005 | US6979681 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer |
| 12/27/2005 | CA2356325C Topical compositions comprising protected functional thiols |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
| 12/22/2005 | WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents |
| 12/22/2005 | WO2005121091A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |